Insights On Partnering
-
The Asia Advantage: Why US Biotechs Should Look East For Clinical Trials
8/7/2024
Explore the compelling reasons behind the Asia Advantage and highlights how Avance Clinical's strategic expansion into the region supports biotechs in maximizing these benefits.
-
Delivering Specialist Neurology Support
4/17/2025
Explore a strategic approach to a Parkinson’s disease trial that leveraged a global infrastructure and multilingual workforce to provide seamless operational and clinical support.
-
Early Phase Clinical Trial Enrollment: How To Avoid Delays From The Start
1/22/2026
By operationalizing the early-phase strategies discussed in this article, trial teams can ensure that foundational safety and efficacy data are captured without the delays that derail studies.
-
Podcast — Strategic Site Identification: A Proven Approach
11/20/2024
Watch our new podcast to discover Altasciences' unique process for identifying and selecting the right clinical sites for your unique project.
-
The Vendor Selection Blunder: An Expensive Oversight In Clinical Trials
10/21/2025
Vendor selection isn’t just procedural — it shapes trial outcomes. Even with a solid process, missteps can ripple through timelines, budgets, and team morale. Choose wisely.
-
The Future Of Oncology Research: Trends And Predictions
5/6/2025
In a clinical trial landscape defined by innovation and empathy, oncology CROs are essential to shaping the future of cancer research.
-
EHR-To-EDC: Choosing The Right Solution For Clinical Trials
12/13/2024
Here we highlight key advantages of EHR-to-EDC eSource, such as cost-effectiveness and improved site satisfaction.
-
Navigating Autoimmune Disease A Playbook For Cell And Gene Therapies
9/3/2025
By integrating site readiness, patient engagement, and data-driven decision-making, the cell and gene therapies (CAGT) field is advancing toward therapies that not only control disease but transform lives.
-
Demystifying Cell And Gene Therapy Studies In Australia And The Broader APAC Region
11/17/2024
Though conducting your clinical trial in Australia may initially seem daunting, the benefits are ample. Australia is home to qualified CRO partners that will guide your CGT to regulatory success.
-
Targeted Protein Degraders: Transforming Oral Therapeutics
8/11/2025
CDMOs play a critical role in TPD development by offering specialized infrastructure and analytical capabilities to support the transition from preclinical research to clinical supply and commercialization.